Drop in PSA screening linked to increase in metastatic prostate cancer

Reductions in prostate-specific antigen (PSA) screening are associated with increases in the incidence of metastatic prostate cancer at diagnosis, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held virtually from Feb. 11 to 13. Vidit Sharma, M.D., from the University of California Los Angeles, and colleagues examined […]

Continue Reading

Nanoparticle drug delivery technique shows promise for treating pancreatic cancer

Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. Encapsulating cancer drugs in nanoparticles shows potential to target tumors more effectively and avoid danger to other parts of the body. The study […]

Continue Reading